Works matching IS 1044307X AND DT 2021 AND VI 33 AND IP 1

Results: 8

Home pregnancy tests--Is ectopic always on your mind? When a patient presents to the ED reporting early pregnancy and intermittent vaginal bleeding, failure to evaluate for ectopic pregnancy can expose clinicians to liability.

Published in:

OBG Management, 2021, v. 33, n. 1, p. 43, doi. 10.12788/obgm.0064

By:

Sanfilippo, Joseph S.;
Smith, Steven R.

Publication type:

Article

When ultrasonography reveals a fetal abdominal wall defect: Although these fetal defects are rare, be alert to their potential presence when early ultrasonography indicates structural abnormalities. Here, surveillance, planning, and appropriate patient counseling are reviewed

Published in:

OBG Management, 2021, v. 33, n. 1, p. 34, doi. 10.12788/obgm.0058

By:

Juusela, Alexander L.;
Gimovsky, Martin

Publication type:

Article

Is it safe to be pregnant during the COVID-19 pandemic? Expert answers to 8 of your most pressing questions about coronavirus disease 2019 and pregnancy, including vaccination.

Published in:

OBG Management, 2021, v. 33, n. 1, p. 28, doi. 10.12788/obgm.0063

By:

Prabhu, Malavika

Publication type:

Article

Pessaries for POP and SUI: Their fitting, care, and effectiveness in various disorders: A refresher on how to fit a pessary, instructions for patients, goals for pessary aftercare visits, and the various conditions for which pessaries may or may not be effective

Published in:

OBG Management, 2021, v. 33, n. 1, p. 20, doi. 10.12788/obgm.0057

By:

Lerner, Henry M.

Publication type:

Article

UPDATE Obstetrics.

Published in:

OBG Management, 2021, v. 33, n. 1, p. 14, doi. 10.12788/obgm.0059

By:

Pauli, Jaimey M.;
Maines, Jaimie L.

Publication type:

Article

Does last contraceptive method used impact the return of normal fertility?

Published in:

OBG Management, 2021, v. 33, n. 1, p. 10, doi. 10.12788/obgm.0060

By:

Hofler, Lisa;
Dale, Lindsay

Publication type:

Article

Optimizing the use of oxytocin on labor and delivery: Oxytocin is the most common hormone administered in obstetrics. Reducing variation in the use of this agent will improve patient safety.

Published in:

OBG Management, 2021, v. 33, n. 1, p. 7, doi. 10.12788/obgm.0061

By:

Barbieri, Robert L.

Publication type:

Article

Two at-home apps for patients with pelvic floor disorders.

Published in:

OBG Management, 2021, v. 33, n. 1, p. 1, doi. 10.12788/obgm.0062

By:

Chen, Katherine T.

Publication type:

Article